#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15242	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2424	769.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1608	1608	C	926	C,A	924,2	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25900	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3971	810.8	0	.	n	.	0	T695C	SNP	695	695	T	1273	1273	C	897	C,G,T	894,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25900	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3971	810.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1915	1915	A	1048	A,G	1046,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25900	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3971	810.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2549	2549	C	939	C,T,A,G	934,2,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25900	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3971	810.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2623	2623	A	883	A,T,C	881,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25900	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3971	810.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	3175	3175	C	901	C,A	900,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	2128	folP	855	855	100.0	folP.l15.c4.ctg.1	2006	132.2	1	SNP	p	R229S	1	.	.	685	687	AGC	1244	1246	AGC	208;208;210	A;G;C	208;208;210	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4866	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3897	155.6	1	SNP	p	S91F	1	.	.	271	273	TTC	846	848	TTC	171;171;171	T;T;C	171;171;171	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4866	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3897	155.6	1	SNP	p	G95N	0	.	.	283	285	GGC	858	860	GGC	170;171;171	G;G,C;C,A	170;170,1;170,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4866	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3897	155.6	1	SNP	p	D95G	1	.	.	283	285	GGC	858	860	GGC	170;171;171	G;G,C;C,A	170;170,1;170,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	2034	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1905	133.0	1	SNP	p	G45D	0	.	.	133	135	GGC	698	700	GGC	224;220;223	G;G,T;C,T	224;219,1;222,1	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1090	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1600	84.9	0	.	n	.	0	A197.	DEL	197	197	A	883	883	A	208	A,G	207,1	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4848	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3547	170.0	1	SNP	p	D86N	0	.	.	256	258	GAC	868	870	GAC	217;214;212	G;A,C;C	217;213,1;212	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4848	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3547	170.0	1	SNP	p	R87W	0	.	.	259	261	CGT	871	873	CGT	214;215;215	C,A;G,A;T	213,1;214,1;215	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4848	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3547	170.0	1	SNP	p	R87I	0	.	.	259	261	CGT	871	873	CGT	214;215;215	C,A;G,A;T	213,1;214,1;215	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4848	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3547	170.0	1	SNP	p	S87R	1	.	.	259	261	CGT	871	873	CGT	214;215;215	C,A;G,A;T	213,1;214,1;215	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4848	parC	2304	2304	100.0	parC.l15.c17.ctg.1	3547	170.0	1	SNP	p	S88P	0	.	.	262	264	TCC	874	876	TCC	212;213;213	T,G;C;C	211,1;213;213	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3930	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3136	155.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1775	1777	GGC	203;203;200	G;G;C	203;203;200	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	4138	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2798	184.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1452	1454	GCA	245;248;249	G;C;A	245;248;249	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4138	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2798	184.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1455	1457	ATC	249;248;245	A;T;C	249;248;245	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4138	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2798	184.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1467	1469	GTG	249;250;253	G;T;G	248;249;252	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4138	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2798	184.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1467	1469	GTG	249;250;253	G;T;G	248;249;252	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4138	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2798	184.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1971	1973	ACC	245;246;248	A;C;C,G	245;246;247,1	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4138	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2798	184.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2025	2027	GCG	230;229;227	G;C;G,C	230;229;226,1	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4138	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2798	184.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2025	2027	GCG	230;229;227	G;C;G,C	230;229;226,1	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4138	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2798	184.1	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2148	2150	AGC	221;222;220	A;G;C	221;222;220	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4138	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2798	184.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2157	2159	GGC	214;216;217	G;G,A;C,T	214;215,1;216,1	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	4138	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2798	184.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2175	2177	CCG	222;225;232	C;C;G	222;225;232	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5706	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	3582	198.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1943	1945	CCG	208;210;213	C;C;G,T	208;210;212,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2218	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2256	122.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	763	763	C	172	C	172	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	332	porB1a	984	226	90.71	porB1a.l15.c17.ctg.3	261	32.2	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	22;24;28	T;T;A	22;24;28	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	332	porB1a	984	226	90.71	porB1a.l15.c17.ctg.3	261	32.2	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	63;63;63	C;A;T	63;63;63	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	332	porB1a	984	226	90.71	porB1a.l15.c17.ctg.3	261	32.2	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	63;63;63	A;G;T	63;63;63	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	332	porB1a	984	226	90.71	porB1a.l15.c17.ctg.3	261	32.2	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	63;63;63	T,C;A;C	62,1;63;63	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	332	porB1a	984	226	90.71	porB1a.l15.c17.ctg.3	261	32.2	0	.	p	.	0	R307E	NONSYN	919	921	AGA	161	163	GAA	2;2;2	G;A;A	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	332	porB1a	984	226	90.71	porB1a.l15.c17.ctg.3	261	32.2	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	2;2;2	G;C;A	2;2;2	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	332	porB1a	984	226	90.71	porB1a.l15.c17.ctg.3	261	32.2	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	3;3;3	A;T;C	3;3;3	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	332	porB1a	984	226	90.71	porB1a.l15.c17.ctg.3	261	32.2	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	3;3;4	T;C;G	3;3;4	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	332	porB1a	984	226	90.71	porB1a.l15.c17.ctg.3	261	32.2	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	4;4;4	G;C;C	4;4;4	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	332	porB1a	984	226	90.71	porB1a.l15.c17.ctg.3	261	32.2	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	4;4;4	A;G;C	4;4;4	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	332	porB1a	984	226	90.71	porB1a.l15.c17.ctg.3	261	32.2	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	5;5;5	G;C;C	5;5;5	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	332	porB1a	984	226	90.71	porB1a.l15.c17.ctg.3	261	32.2	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	5;5;5	G;T;T	5;5;5	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3080	porB1b	1035	1035	98.75	porB1b.l6.c17.ctg.1	2054	185.6	0	.	p	.	0	R143G	NONSYN	427	429	AGA	1047	1049	GGA	272;270;268	G,A;G,A;A	269,2;267,2;267	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3080	porB1b	1035	1035	98.75	porB1b.l6.c17.ctg.1	2054	185.6	0	.	p	.	0	.	INDELS	629	630	AA	1250	1252	TAG	264;267;263	T,C;A,T;G,T,A	263,1;266,1;261,1,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3080	porB1b	1035	1035	98.75	porB1b.l6.c17.ctg.1	2054	185.6	0	.	p	.	0	.	MULTIPLE	631	633	TAC	1254	1257	CAAT	265;262;265;262	C,A,T;A;A;T,A,C	263,1,1;262;265;259,2,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3080	porB1b	1035	1035	98.75	porB1b.l6.c17.ctg.1	2054	185.6	0	.	p	.	0	N212fs	FSHIFT	634	634	A	1259	1259	T	257	T	257	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3080	porB1b	1035	1035	98.75	porB1b.l6.c17.ctg.1	2054	185.6	1	SNP	p	G120K	0	.	.	358	360	GGT	978	980	GGT	253;253;256	G,A;G,C,A;T,G	252,1;251,1,1;254,2	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3080	porB1b	1035	1035	98.75	porB1b.l6.c17.ctg.1	2054	185.6	1	SNP	p	A121N	0	.	.	361	363	GCC	981	983	GCC	255;257;260	G;C,A;C	255;256,1;259	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3080	porB1b	1035	1035	98.75	porB1b.l6.c17.ctg.1	2054	185.6	1	SNP	p	A121D	0	.	.	361	363	GCC	981	983	GCC	255;257;260	G;C,A;C	255;256,1;259	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10720	rpoB	4179	4179	99.98	rpoB.l6.c4.ctg.1	5461	244.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1526	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1442	131.5	1	SNP	p	V57M	1	.	.	169	171	ATG	742	744	ATG	291;291;290	A;T;G	291;291;290	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
